Deep Track Capital, LP
- SEC CIK
- 0001856083
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only.
- Positions
- 49
- No filing for Q3 2021
- Portfolio value
- $1.35B
- No filing for Q3 2021
Deep Track Capital, LP did not file a 13F for Q3 2021, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KROSKeros Therapeutics, Inc. | COM | 1,300,000 | $76.1M | 5.6% | – | – | History |
| TVTXTravere Therapeutics, Inc. | COM | 2,450,000 | $76.0M | 5.6% | – | – | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,100,000 | $67.0M | 4.9% | – | – | History |
| ISEEIVERIC bio, Inc. | COM | 4,000,000 | $66.9M | 4.9% | – | – | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 500,000 | $63.7M | 4.7% | – | – | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 2,000,000 | $58.5M | 4.3% | – | – | History |
| BEAMBeam Therapeutics Inc. | COM | 700,000 | $55.8M | 4.1% | – | – | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,900,000 | $54.0M | 4.0% | – | – | History |
| RPTXRepare Therapeutics Inc. | COM | 2,100,000 | $44.3M | 3.3% | – | – | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 500,000 | $42.4M | 3.1% | – | – | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 1,900,000 | $41.7M | 3.1% | – | – | History |
| NVCRNovoCure Ltd | ORD SHS | 550,000 | $41.3M | 3.1% | – | – | History |
| IMVTImmunovant, Inc. | COM | 4,775,000 | $40.7M | 3.0% | – | – | History |
| KDNYChinook Therapeutics, Inc. | COM | 2,420,502 | $39.5M | 2.9% | – | – | History |
| KURAKura Oncology, Inc. | COM | 2,550,000 | $35.7M | 2.6% | – | – | History |
| DICEDICE Therapeutics, Inc. | COM | 1,341,004 | $33.9M | 2.5% | – | – | History |
| JNCEJounce Therapeutics, Inc. | COM | 4,000,000 | $33.4M | 2.5% | – | – | History |
| ESPREsperion Therapeutics, Inc. | COM | 5,641,668 | $28.2M | 2.1% | – | – | History |
| DYNDyne Therapeutics, Inc. | COM | 2,292,250 | $27.3M | 2.0% | – | – | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,336,690 | $26.4M | 2.0% | – | – | History |
| FATEFate Therapeutics Inc | COM | 418,037 | $24.5M | 1.8% | – | – | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,000,000 | $23.8M | 1.8% | – | – | – |
| GRTSGritstone bio, Inc. | COM | 1,771,801 | $22.8M | 1.7% | – | – | History |
| SLNSilence Therapeutics plc | ADS | 950,798 | $22.7M | 1.7% | – | – | History |
| TCDATricida, Inc. | COM | 2,335,143 | $22.3M | 1.7% | – | – | History |
| DNTHDianthus Therapeutics, Inc. | COM | 4,870,000 | $21.6M | 1.6% | – | – | History |
| SAGESage Therapeutics, Inc. | COM | 500,000 | $21.3M | 1.6% | – | – | History |
| PASGPassage BIO, Inc. | COM | 3,216,997 | $20.4M | 1.5% | – | – | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,500,000 | $19.8M | 1.5% | – | – | History |
| NKTXNkarta, Inc. | COM | 1,264,426 | $19.4M | 1.4% | – | – | History |
| VERVVerve Therapeutics, Inc. | COM | 500,000 | $18.4M | 1.4% | – | – | History |
| KRTXKaruna Therapeutics, Inc. | COM | 130,200 | $17.1M | 1.3% | – | – | History |
| TNYATenaya Therapeutics, Inc. | COM | 762,317 | $14.4M | 1.1% | – | – | History |
| PTGXProtagonist Therapeutics, Inc | COM | 421,660 | $14.4M | 1.1% | – | – | History |
| FULCFulcrum Therapeutics, Inc. | COM | 750,000 | $13.3M | 1.0% | – | – | History |
| SRRASierra Oncology, Inc. | COM NEW | 607,600 | $13.2M | 1.0% | – | – | History |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 1,933,040 | $13.1M | 1.0% | – | – | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 750,000 | $11.8M | 0.9% | – | – | History |
| GHRSGH Research PLC | ORDINARY SHARES | 499,400 | $11.7M | 0.9% | – | – | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 80,000 | $10.8M | 0.8% | – | – | History |
| ATYRaTYR PHARMA INC | COM NEW | 1,100,000 | $8.22M | 0.6% | – | – | History |
| VNDAVanda Pharmaceuticals Inc. | COM | 500,000 | $7.84M | 0.6% | – | – | History |
| ASMBAssembly Biosciences, Inc. | COM | 3,000,000 | $6.99M | 0.5% | – | – | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 400,000 | $4.50M | 0.3% | – | – | History |
| TECXTectonic Therapeutic, Inc. | COM | 1,050,132 | $4.04M | 0.3% | – | – | History |
| IPSCCentury Therapeutics, Inc. | COM | 250,000 | $3.96M | 0.3% | – | – | History |
| CNTBConnect Biopharma Holdings Ltd | ADS | 647,057 | $3.33M | 0.2% | – | – | History |
| ONCROncorus, Inc. | COM | 600,000 | $3.16M | 0.2% | – | – | History |
| RFLRafael Holdings, Inc. | COM CL B | 285,714 | $1.46M | 0.1% | – | – | History |
Options (6)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| ACADAcadia Pharmaceuticals Inc | COM | – | $23.3M |
| SAGESage Therapeutics, Inc. | COM | – | $17.0M |
| VNDAVanda Pharmaceuticals Inc. | COM | – | $7.84M |
| NKTRNektar Therapeutics | COM | $6.75M | – |
| BBIOBridgeBio Pharma, Inc. | COM | – | $6.67M |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | $1.98M | – |